Comparative effectiveness and child health

Lisa A Prosser1

  • 1Child Health Evaluation and Research Unit, Division of General Pediatrics, University of Michigan Medical School, Ann Arbor, MI 48109, USA. lisapros@med.umich.edu

Pharmacoeconomics
|July 14, 2012
PubMed

Insights

Comparative effectiveness research (CER) for child health needs special methods. Adapting CER ensures better clinical and policy decisions for pediatric populations.

Area of Science:

  • Pediatric Health Research
  • Health Services Research
  • Comparative Effectiveness Research

Background:

  • Comparative effectiveness research (CER) is crucial for US clinical and policy decisions.
  • Applying CER to child health requires unique considerations beyond adult populations.

Purpose of the Study:

  • To discuss the specific adaptations needed for applying CER methodologies to child health.
  • To highlight challenges and propose solutions for pediatric CER.

Main Methods:

  • Discussion of how standard CER aspects (study design, evidence synthesis, outcomes) differ for children.
  • Exploration of decision analysis as a tool for synthesizing pediatric data and projecting long-term effectiveness.

Main Results:

  • CER in child health must account for parent/caregiver roles, age-related effectiveness variations, and lifespan outcome projections.
  • Existing CER frameworks require expanded definitions for pediatric applications.

Conclusions:

  • Tailoring CER methods is essential for generating robust evidence in child health.
  • This adaptation will significantly improve clinical and policy decision-making for children's health outcomes.

Related Concept Videos

Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Models of Health Promotion and Illness Prevention II01:18

Models of Health Promotion and Illness Prevention II

The person's health status fluctuates continually, varying from being in good health to becoming ill and returning to being healthy. To understand the concept of illness prevention, there are two models. First, the health-illness continuum model is a graphic representation of an individual's wellness. It states that a person is considered healthy in the absence of physical disease and the presence of good emotional health.
The agent-host-environment model states that disease results from...
Primary Healthcare Services01:30

Primary Healthcare Services

Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...